                               SEQUENCE LISTING

<110> DUKE UNIVERSITY
 
<120> LASOFOXIFENE TREATMENT OF BREAST CANCER

<130> 32524-33498/PCT

<140>
<141>

<150> 62/502,299
<151> 2017-05-05

<150> 62/457,759
<151> 2017-02-10

<150> 62/406,859
<151> 2016-10-11

<160> 8     

<170> PatentIn version 3.5

<210> 1
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
aatgacctgc tgctggagat g                                                 21


<210> 2
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 2
gaggggcacc acgttcttgc a                                                 21


<210> 3
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 3
gacctgctgc tggagatgct g                                                 21


<210> 4
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 4
gctgaggggc accacgttct t                                                 21


<210> 5
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 5
tgtgacctgc tgctggagat g                                                 21


<210> 6
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 6
gctgaggggc accacgttct t                                                 21


<210> 7
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 7
ggtctgctgc tggagatgct g                                                 21


<210> 8
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 8
atagaggggc accacgttct t                                                 21


